Giresun University Faculty of Medicine Department of General Surgery Giresun Turkey

Giresun University Faculty of Medicine Department of Pathology Giresun Turkey

Giresun University Faculty of Medicine Division of Endocrine Surgery Giresun Turkey

onu University Faculty of Medicine Department of Surgery Liver Transplantation Institute Malatya Turkey

Ostrava University Faculty of Medicine Department of Surgery Ostrava Czechia

Tomas Bata University in Zlin Department of Surgery Zlin Czechia

University Hospital Ostrava Department of Surgery Ostrava Czechia

Rev Assoc Med Bras (1992). 2022 Aug;68(8):1126. doi: 10.1590/1806-9282.20220268ERRATUM. PubMed

See more in PubMed

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi: 10.1002/hep.28431. PubMed DOI

Ascha MS, Hanouneh IA, Lopez R, Tamimi TA-R, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Hepatology. 2010;51(6):1972–1978. doi: 10.1002/hep.23527. PubMed DOI

Kew MC. Obesity as a cause of hepatocellular carcinoma. Ann Hepatol. 2015;14(3):299–303. doi: 10.1016/S1665-2681(19)31267-0. PubMed DOI

Sempokuya T, Wong LL. Ten-year survival and recurrence of hepatocellular cancer. Hepatoma Res. 2019;5(38) doi: 10.20517/2394-5079.2019.013. PubMed DOI PMC

Hashimoto E, Yatsuji S, Tobari M, Taniani M, Torii M, Tokushige K, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Gastroenterol. 2009;44(Suppl 19):89–95. doi: 10.1007/s00535-008-2262-x. PubMed DOI

Salomao M, Woojin MY, Brown RS, Emond JC, Lefkowitch JH. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol. 2010;34(11):1630–1636. doi: 10.1097/PAS.0b013e3181f31caa. PubMed DOI

Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology. 2008;155(6):1828–1837. doi: 10.1053/j.gastro.2018.08.024. PubMed DOI PMC

White DL, Kanwal F, El-Serag HB. Association between non-alcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012;10(12):1342–1359. doi: 10.1016/j.cgh.2012.10.001. e2. PubMed DOI PMC

Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, et al. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. BMC Med. 2019;17(1):95–95. doi: 10.1186/s12916-019-1321-x. PubMed DOI PMC

Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of non alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123(1):134–140. doi: 10.1053/gast.2002.34168. PubMed DOI

Takakura K, Oikawa T, Nakano M, Saeki C, Torisu Y, Kajihara M, et al. Recent insights into the multiple pathways driving non-alcoholic steatohepatitis-derived hepatocellular carcinoma. Front Oncol. 2019;9:762–762. doi: 10.3389/fonc.2019.00762. PubMed DOI PMC

Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330–9337. doi: 10.3748/wjg.v20.i28.9330. PubMed DOI PMC

Chang Y, Jung HS, Cho J, Zhang Y, Yun KE, Lazo M, et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am J Gastroenterol. 2016;111(8):1133–1140. doi: 10.1038/ajg.2016.178. PubMed DOI

Bertola A, Bonnafous S, Anty R, Patouraux S, Iannelli A, et al. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One. 2010;5(10):e13577–e13577. doi: 10.1317/journal.pone.0013577. PubMed DOI PMC

Baidal JAW, Lavine JE. The intersection of nonalcoholic fatty liver disease and obesity. Sci Transl Med. 2016;8(323):323rv1–323rvl. doi: 10.1126/scitranslmed.aad8390. PubMed DOI

Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab. 2008;19(10):371–379. doi: 10.1016/j.tem.2008.08.005. PubMed DOI

Toman D, Sengul I, Pelikán A, Sengul I, Vavra P, Ihnat I, et al. Hepatocellular carcinoma versus non-alcoholic fatty liver disease: metabolic, environmental, and genetic association? De facto? Rev Assoc Med Bras. 2022;68 Epub ahead of print. PubMed

Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29(3):664–669. doi: 10.1002/hep.510290347. PubMed DOI